AcelRx Pharma Stock Price (NASDAQ:ACRX)

Add to My Stocks
$2.6 $0 (0%) ACRX stock closing price Apr 28, 2017 (Closing)
Prev Close* : $2.60
Market Cap:
$117.88M
Day Low: $2.6
52 Week Low: $2.40
Open: $2.6
Volume: 100622
Day High: $2.65
52 Week High: $4.08
Dividend:
N/A

Latest Stock Market News

Latest Articles

AcelRx Pharma News - From Partners

ACRX Stockcharts

View ACRX PE ratio, PS ratio stocks charts and compare with peers.
ACRX Chart
Note: Compare AcelRx Pharma stock price history with the index and industry peers.

AcelRx Pharma Valuation

PS ratio (
price to sales ratio
)
6.79
PB ratio (
price to book ratio
)
8.67

AcelRx Pharma Financial Ratios

Asset Turnover
0.25
Receivables Turnover
4.7

ACRX Industry Peers

Company Price Change (%)
Durect (DRRX)0.880 (0%)
Steadymed (STDY)7.20.85 (13.39%)
Depomed (DEPO)11.990.16 (1.32%)
Biodelivery Sciences (BDSI)1.830.13 (7.65%)
Cara Therapeutics (CARA)15.890.07 (0.44%)
Acura Pharma (ACUR)0.520.01 (1.89%)
Egalet (EGLT)3.820.26 (6.37%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cempra (CEMP)4.30.45 (11.69%)
United Therapeutics (UTHR)125.75.2 (4.32%)
Nutraceutical International (NUTR)31.70.95 (3.09%)
La Jolla Pharma (LJPC)290.82 (2.91%)
Grifols (GRFS)21.710.54 (2.55%)
Infinity Pharma (INFI)2.150.05 (2.38%)
Genocea Biosciences (GNCA)6.390.14 (2.24%)
Top gainers from Medical-Drugs industry
* As of Apr 29, 2017
CompanyPriceChange (%)
Egalet (EGLT)3.820.26 (6.37%)
MADRIGAL PHARMA (MDGL)16.51 (5.71%)
Adamis Pharma (ADMP)3.70.2 (5.13%)
MediWound (MDWD)60.3 (4.76%)
GlycoMimetics (GLYC)4.30.21 (4.66%)
Galectin Therapeutics (GALT)3.060.12 (3.77%)
AVADEL PHARMA (AVDL)9.490.33 (3.36%)
Top losers from Medical-Drugs industry
* As of Apr 29, 2017

AcelRx Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues17.35M19.26M5.21M29.5M2.39M
Net Income-43.15M-24.39M-33.35M-23.42M-33.36M
Total Operating Expense36.99M37.43M42.86M36.16M32.09M
view AcelRx Pharmaceuticals Inc income statement
balance sheet20162015201420132012
Total Assets99.99M127.78M86.44M110.03M64.52M
Total Liabilities105.33M94.67M39.79M36.87M30.67M
Shareholders Equity-5.33M33.11M46.65M73.15M33.84M
view AcelRx Pharmaceuticals Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-2.27M-4.42M-0.13M2.95M3.51M
Net Cash From (Used By) Operating Activities-29.39M-19.95M-34.45M-0.48M-24.58M
Increase (Decrease) In Prop Plant And Equipment-3.72M-1.45M-5.5M-3.28M-0.82M
view AcelRx Pharmaceuticals Inc cashflow statement

AcelRx Pharma Stock Message Board

AcelRx Pharma stock lost 0 %, and the last close price as of 28 Apr, 2017 is 2.6 for ACRX stock. AcelRx Pharma market capitalization is 117.88M and it represents the total market value of ACRX stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing AcelRx Pharma stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that AcelRx Pharma is worth a lot, it will most likely be reflected in an inflated AcelRx Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 100622 shares were traded with a closing stock price of 2.6 as of 28 Apr, 2017, as can be seen from AcelRx Pharma stock quote. One can view AcelRx Pharma stock chart to follow the stock price trend. To check the historical stock price movement, all time high, and all time low of ACRX, view AcelRx Pharma stock price history.